APIs for research and impurities
Subcategories of "APIs for research and impurities"
- Aminoacids and derivatives(12,444 products)
- Anthraquinones and derivatives(407 products)
- Benzimidazole and Imidazole Derivatives(10,465 products)
- Benzodiazepine Derivatives(335 products)
- Carbohydrates and glycoconjugates(5,389 products)
- Esters and Derivatives(42,308 products)
- Fatty Acids and Lypidic Derivatives(32,489 products)
- Flavonoids and Polyphenols(17,102 products)
- Free Radicals and Oxidant/Reducing Agents(215 products)
- Ketones and derivatives(2,692 products)
- Natural and semi-synthetic antibiotics(6,414 products)
- Nitriles and Cyano Derivatives(3,070 products)
- Nitrosamines and Derivatives(55 products)
- Nucleosides and Nucleotides(3,494 products)
- Organic Phosphates and Phosphonates(1,205 products)
- Organic Sulphonates and Sulphates(10,452 products)
- Organometallics(4,425 products)
- Others(6,340 products)
- Peptides and Proteins(3,163 products)
- Polymers and Derivatives(100 products)
- Purines and Pyrimidine Derivatives(8,976 products)
- Quinazoline and Quinoline Derivatives(66,237 products)
- Quinones and Derivatives(24,381 products)
- Salts and Derivatives of Active Pharmaceutical Ingredients (API)(92,986 products)
- Steroids and Derivatives(4,987 products)
- Sulfonamides and Derivatives(2,607 products)
- Terpenoids and Derivatives(3,871 products)
- Thiazolidinediones and Thiopyrans(2,755 products)
- β-Adrenergic Compounds(232 products)
Found 66910 products of "APIs for research and impurities"
(S)-(+)-4-Phenyl-2-oxazolidinone
CAS:(S)-(+)-4-Phenyl-2-oxazolidinone is a synthetic, white to off-white solid that is soluble in water and ethanol. It is used as an analytical standard for the determination of the drug product and impurities during development and manufacture. The CAS number for (S)-(+)-4-Phenyl-2-oxazolidinone is 99395-88-7.Formula:C9H9NO2Purity:Min. 95%Molecular weight:163.17 g/molOlmesartan EP Impurity C
CAS:Olmesartan medoxomil is a prodrug that is metabolized to the active form, olmesartan, in the liver. The esters of olmesartan medoxomil are metabolized by hydrolysis and by esterases. The most common side effects of olmesartan medoxomil are headache, dizziness, fatigue, nausea and diarrhea. Olmesartan medoxomil is used for the treatment of high blood pressure in adults. This drug also has anti-inflammatory properties due to its inhibition of prostaglandin synthesis.
Formula:C29H28N6O5Purity:Min. 95%Color and Shape:White Off-White PowderMolecular weight:540.57 g/molOxytocin
CAS:Natriuretic hormone; induces uterine contraction and lactation
Formula:C43H66N12O12S2Purity:Min. 98 Area-%Color and Shape:White Off-White PowderMolecular weight:1,007.19 g/molLevonorgestrel EP Impurity P
CAS:Soluble in Chloroform & in Methanol Confirmed
Insoluble in WatePurity:90% minColor and Shape:Off White or Beige SolidMolecular weight:312.45Rotogotine EP impurity J
Rotogotine EP impurity J is a synthetic compound that is used as an impurity standard in the manufacture of rotogotine EP. It is a metabolite of rotogotine and has been shown to have pharmacological effects on animals. Rotogotine EP impurity J has been shown to have a high level of purity and is suitable for use as an analytical reference material in drug development, metabolism studies, and HPLC standards.Purity:Min. 95%5-Hydroxy duloxetine
CAS:5-Hydroxy duloxetine (5HD) is a drug product that is synthesized by Custom Synthesis. It has high purity and analytical specifications, and can be used for metabolism studies, natural product development, pharmacopoeia, and research and development. 5HD also has a CAS number of 741693-77-6. This product is synthetically produced with impurity standards. The molecular weight of 5HD is 236.3 g/mol with an impurity level of less than 1%. 5HD can be used in the following applications: HPLC standard, HPLC calibration standard, Impurity standard for LCMS, Impurity standard for GCMS.
Formula:C18H19NO2SPurity:Min. 95%Color and Shape:PowderMolecular weight:313.40 g/molEthyl-(5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate, racemic
CAS:Ethyl (5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate, racemic) is a molecule that can be used in the treatment of cardiac diseases. It is a cardiotonic agent that has been shown to shorten the duration of ventricular fibrillation and restore contractility. This drug also decreases the frequency and severity of angina pectoris and enhances coronary artery blood flow. The most effective dose for this drug is 1.5 mg per kg body weight. It is administered orally or intravenously and should not be used with fatty esters because it may cause hypotension. Ethyl (5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate, racemic) has been shown to have an effect on metal coordination profiles as well as an activated form of the molecule.Formula:C17H17O3NPurity:Min. 98 Area-%Color and Shape:Off-White PowderMolecular weight:283.32 g/mol3-[[[2-[(Diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl]propanoic acid
CAS:3-[[[2-[(Diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl]propanoic acid is a pharmaceutical agent. It is used in the treatment of heartburn, gastroesophageal reflux disease (GERD), and other conditions. 3-[[[2-[(Diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl]propanoic acid is a prodrug that is hydrolyzed to famotidine, its active form, in the body. Famotidine has been shown to inhibit the H+/K+ ATPase enzyme from gastric parietal cells, which increases intracellular pH and reduces gastric acid secretion. 3-[[[2-[(Diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl]propanoic acid also inhibitsFormula:C8H12N4O2S2Purity:Min. 95%Color and Shape:PowderMolecular weight:260.34 g/mol2,4-Dicyano-3-(3,4-dihydroxy-5-nitrophenyl)-N1,N1,N5,N5-tetraethylpentanediamide
2,4-Dicyano-3-(3,4-dihydroxy-5-nitrophenyl)-N1,N1,N5,N5-tetraethylpentanediamide is a white crystalline solid that is used as an analytical reference standard in HPLC. It is used for the determination of purity and impurities in pharmaceuticals and drug products. This compound can be custom synthesized or obtained from natural sources. It can be found in the USP Drug Impurity Standards and the European Pharmacopoeia.Formula:C21H27N5O6Purity:Min. 95%Molecular weight:445.47 g/molAmikacin EP Impurity A
CAS:Amikacin EP Impurity A is a metabolite of amikacin. It is a white crystalline substance with a molecular weight of 269.5. Amikacin EP Impurity A is found in the urine and bile of individuals who have been administered amikacin. It has been shown to be pharmacologically active, inhibiting bacterial growth by binding to DNA-dependent RNA polymerase, thereby preventing transcription and replication.Formula:C22H43N5O13Purity:Min. 95%Molecular weight:585.6 g/molN-Methyl-3-(4-naphthol)-3-(2-thienyl) propanamine hydrochloride
CAS:N-Methyl-3-(4-naphthol)-3-(2-thienyl) propanamine hydrochloride is a custom synthesis that has been shown to be a metabolite of naphthalene. It has been used as an impurity standard for N-methyl-3-(4-naphthol)-2-[(5-nitrofuran-2-yl)methyl] propanamine and in metabolism studies.Formula:C18H19NOS•HClPurity:Min. 95%Color and Shape:PowderMolecular weight:333.88 g/mol5-(2-Cyclopropyl-1-(3-fluorophenyl)-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate
CAS:5-(2-Cyclopropyl-1-(3-fluorophenyl)-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate is a substance that is used as a reference in high performance liquid chromatography (HPLC) methods. It is used to validate the method in accordance with the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The substance is also known as prasugrel hydrochloride and it is used as an antiplatelet agent.Formula:C20H20FNO3SPurity:Min. 95 Area-%Color and Shape:Slightly Yellow PowderMolecular weight:373.44 g/mol3-O-Methylcarbidopa
CAS:Controlled Product3-O-Methylcarbidopa is a drug that belongs to the class of dopa decarboxylase inhibitors. It is an inactive prodrug, which is converted into its active form by hydrolysis in the body. 3-O-Methylcarbidopa has been shown to have a plasma concentration that can be detected, with an elimination rate of about 4 hours. The active substance is found in the particle size range of 0.1 to 1 micrometer and can be analyzed using chromatographic methods. 3-O-Methylcarbidopa is primarily used for the treatment of Parkinson's disease, but also has potential applications in other diseases such as Alzheimer's disease, depression and schizophrenia.Purity:Min. 95%Molecular weight:240.26[(2-Butoxyethoxy)ethyl] 2-[(trifluoromethyl)phenylamino]benzoate
CAS:[(2-Butoxyethoxy)ethyl] 2-[(trifluoromethyl)phenylamino]benzoate is a synthetic chemical that is an impurity in the synthesis of the drug product, [(2-butoxyethoxy)ethyl] 2-[(trifluoromethyl)phenylamino]-benzoate. It is a white to off-white solid with a melting point of 53°C. The purity of this compound is high and it has been used as an analytical standard for HPLC. This compound also has niche application in pharmacopoeia and drug development.Formula:C22H26F3NO4Purity:Min. 95%Color and Shape:Pale yellow to yellow liquidMolecular weight:425.44 g/mol1b-(4-Fluorophenyl)hexahydro-β,7-dihydroxy-7-(1-methylethyl)-1a-phenyl-7a-[(phenylamino)carbonyl]-3H-oxireno[3,4]pyrrolo[2,1-b][1,3] oxazine-3-butanoic acid sodium
CAS:Fluoxetine is a selective serotonin reuptake inhibitor that is used to treat major depressive disorder, obsessive-compulsive disorder (OCD), bulimia nervosa, panic disorder, premenstrual dysphoric disorder (PMDD), and social anxiety disorder. It is also used as an appetite suppressant in some countries. Fluoxetine inhibits the neuronal uptake of serotonin by blocking the presynaptic transporter protein. The most common adverse effects are nausea, diarrhea, drowsiness, dry mouth, blurred vision and sexual dysfunction.Formula:C33H35FN2O7•NaPurity:Min. 95%Color and Shape:PowderMolecular weight:613.63 g/mol2-(N-Methyl-propanamine)-3-(2-naphthyl) thiophene
CAS:2-(N-Methyl-propanamine)-3-(2-naphthyl) thiophene is a synthetic compound that has been used as an impurity standard for the drug product and API. It has also been used for the pharmacopoeia, research and development, and analytical purposes. This compound is a metabolite of erythromycin.Formula:C18H19NOSPurity:Min. 95%Color and Shape:White To Pink Or Yellow SolidMolecular weight:297.42 g/molN,N-Dimethyl-2-ene-3-(4-methylbenzoyl)-propionamide
CAS:Dimethyl-2-ene-3-(4-methylbenzoyl)propionamide is an impurity that is found in N,N-dimethyl-3-(4-methylbenzoyl)-propionamide. It is a white solid and has a melting point of 132°C. Dimethyl-2-ene-3-(4-methylbenzoyl)propionamide is not soluble in water or ethanol. This compound is used as a high purity, API impurity, HPLC standard, niche, pharmacopoeia, Custom synthesis, Drug development, analytical and Synthetic drug product. Dimethyl-2-ene-3-(4-methylbenzoyl)propionamide can be metabolized by the liver to 2-[(2E)-1H-[1]benzopyran--5(6H)-ylidene]-N,N'-dimethylethane--3(2H)-carboxFormula:C13H15NO2Purity:Min. 95%Color and Shape:PowderMolecular weight:217.26 g/molDifluoro atorvastatin
CAS:Difluoro atorvastatin is a filtrate of atorvastatin, which is a cholesterol-lowering drug. It is synthesized by reacting butyric acid with atorvastatin in an organic solvent. The reaction solution was filtered to remove impurities and then purified by liquid chromatography. The product was characterized by diffraction and LC-MS analysis. Difluoro atorvastatin has a high purity and is suitable for further use in the preparation of pharmaceuticals.
Formula:C33H34F2N2O5Purity:Min. 95%Molecular weight:576.63 g/mol

